Lantern Pharma Inc. (LTRN) key performance indicators and operating metrics (4 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Number of Patients Enrolled (Phase 1a Trial) | 63.00 | FY2025-Q4 |
| Clinical Benefit Rate | 48.00 percent | FY2025-Q3 |
| Ensemble Machine Learning Accuracy for Blood-Brain Barrier Permeability Prediction | 94.10 percent | FY2025-Q3 |
| Objective Response Rate | 43.00 percent | FY2024-Q4 |
Back to LTRN overview · LTRN earnings · LTRN holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.